Država: Velika Britanija
Jezik: engleski
Izvor: MHRA (Medicines & Healthcare Products Regulatory Agency)
Deferiprone
Swedish Orphan Biovitrum Ltd
V03AC02
Deferiprone
100mg/1ml
Oral solution
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 09010300; GTIN: 0771313172943
1 PACKAGE LEAFLET: INFORMATION FOR THE USER FERRIPROX 100 MG/ML ORAL SOLUTION Deferiprone READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. − Keep this leaflet. You may need to read it again. − If you have any further questions, ask your doctor or pharmacist. − This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. − If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. − Attached to this leaflet you will find a patient/carer reminder card. You should detach, complete, read the card carefully and carry it with you. WHAT IS IN THIS LEAFLET 1. What Ferriprox is and what it is used for 2. What you need to know before you take Ferriprox 3. How to take Ferriprox 4. Possible side effects 5. How to store Ferriprox 6. Contents of the pack and other information 1. WHAT FERRIPROX IS AND WHAT IT IS USED FOR Ferriprox contains the active substance deferiprone. Ferriprox is a medicine that removes iron from the body. Ferriprox is used to treat iron overload caused by frequent blood transfusions in patients with thalassaemia major when current chelation therapy is contraindicated or inadequate. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE FERRIPROX DO NOT TAKE FERRIPROX − if you are allergic to deferiprone or any of the other ingredients of this medicine (listed in section 6). − if you have a history of repeated episodes of neutropenia (low white blood cell (neutrophil) count). − if you have a history of agranulocytosis (very low white blood cell (neutrophil) count). − if you are currently taking medicines known to cause neutropenia or agranulocytosis (see “Other medicines and Ferriprox”). − if you are pregnant or breast-feeding. WARNINGS AND PRECAUTIONS − the most serious side effect that may occur while taking Ferriprox is a very low white blood c Pročitajte cijeli dokument
OBJECT 1 FERRIPROX 100 MG/ML ORAL SOLUTION Summary of Product Characteristics Updated 09-Aug-2017 | Swedish Orphan Biovitrum Ltd 1. Name of the medicinal product Ferriprox 100 mg/ml oral solution 2. Qualitative and quantitative composition Each ml of oral solution contains 100 mg deferiprone (25 g deferiprone in 250 ml and 50 g deferiprone in 500 ml). Excipient with known effect Each ml of oral solution contains 0.4 mg Sunset Yellow (E110). For the full list of excipients, see section 6.1. 3. Pharmaceutical form Oral solution. Clear, reddish orange-coloured liquid. 4. Clinical particulars 4.1 Therapeutic indications Ferriprox monotherapy is indicated for the treatment of iron overload in patients with thalassaemia major when current chelation therapy is contraindicated or inadequate. Ferriprox in combination with another chelator (see section 4.4) is indicated in patients with thalassaemia major when monotherapy with any iron chelator is ineffective, or when prevention or treatment of life- threatening consequences of iron overload (mainly cardiac overload) justifies rapid or intensive correction (see section 4.2). 4.2 Posology and method of administration Deferiprone therapy should be initiated and maintained by a physician experienced in the treatment of patients with thalassaemia. Posology Deferiprone is usually given as 25 mg/kg body weight, orally, three times a day for a total daily dose of 75 mg/kg body weight. Dose per kilogram body weight should be calculated to the nearest 2.5 ml. See table below for recommended doses for body weights at 10 kg increments. _Dose table_ To obtain a dose of about 75 mg/kg/day, use the volume of oral solution suggested in the following table for the body weight of the patient. Sample body weights at 10 kg increments are listed. BODY WEIGHT (KG) TOTAL DAILY DOSE (MG) DOSE (MG, THREE TIMES/DAY) ML OF ORAL SOLUTION (THREE TIMES/DAY) 20 1500 500 5.0 30 2250 750 7.5 40 3000 1000 10.0 50 3750 1250 12.5 60 4500 1500 15.0 70 5250 1750 17.5 80 6000 2000 20.0 90 6750 2250 22.5 A tota Pročitajte cijeli dokument